“…In 2020, FDA implemented sales limitations within the United States; however, these policies were limited in scope, targeting specific flavours and items [38]. Due to the presence of heterogeneity, complexity, and limited transparency in relation to e-cigarette products, there exists a lack of comprehensive understanding regarding the exposures resulting from e-cigarette usage.…”